51 - 75 of 238
Number of results to display per page
TitleCreatorRelation Is Part Of
51 Double-Blind Cross-Over Trial Of Gabapentin And Memantine For Treatment Of Acquired NystagmusM. J. Thurtell; A. C. Joshi; A. C. Leone; R. L. Tomsak; G. S. Kosmorsky; J. S. Stahl; R. J. LeighNANOS 2010: Scientific Platform Presentations
52 The Effect of 4-aminopyridine on the Velocity Versional Dysconjugacy Index (VDI), an Objective Ocular Motor Metric of Dysconjugacy Associated with INO in MS Patients, During High Precision Escalation in Core Body TemperatureTeresa Frohman; Davis Scott; Beh Josh; Conger Amy; Conger Darrell; Remington Gina; Frohman Ashley; Frohman ElliotNANOS 2014: Poster Presentations
53 Emerging Therapies of Multiple SclerosisJeffrey Bennett, MD, PhDNANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art
54 European Perspective - It Could Be MSAxel Petzold, MD, PhD, FRCP, FRCPath, FRCOphthNANOS Annual Meeting 2023: State of the Art - Global Perspectives
55 Existing Therapies for Treatment of MSAri J. Green, MDNANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art
56 Exploring the Oculomotor Effects of Sustained-Release Fampridine in Multiple Sclerosis Patients with Gait Impairment. (.pdf)Cristina Duque; Jose Coelho; Joana Marcal; Isabel Ribeiro; Alda Melo; Carla Nunes; Carmo Macario; Sonia Batista; Livia Abreu; Joao LemosNANOS Annual Meeting 2016: Poster Presentations
57 Exploring the Temporal Evolution of Structural and Functional Changes after Acute Optic NeuritisFiona Costello; Irene Pan; Jodie Burton; Jessie Trufyn; William HodgeNANOS 2013: Platform Presentations (Session I)
58 Extra-Axonal Ocular Damage Quantification by Multifocal Electroretinography in Chronic Progressive Multiple SclerosisArielle R. Spitze; Nagham Al-Zubidi; Sushma Yalamanchili; Fiona Costello; Andrew G. LeeNANOS 2013: Poster Presentations
59 Factors in Optic Nerve Conduction - VEP AnalysisJohn B. Selhorst, MDNANOS 1983: Various Subjects Symposium
60 Familial Multiple Sclerosis Presenting With Familial Intracranial HypertensionBenjamin OsborneNANOS 2010: Poster Presentations
61 The Final 15-Year Follow-up Report on the Neurological Outcome of the Optic Neuritis Treatment TrialM. Tariq BhattiNANOS 2008: Platform Session I
62 Five- to Seven-Year Longitudinal Data for Vision and OCT Retinal Nerve Fiber Layer (RNFL) Thickness in MSStephen J. Moster; Lauren Talman; James Wilson; Kristin Galetta; Reiko Sakai; Steven L. Galetta; Elliot Frohman; Peter Calabresi; Laura J. BalcerNANOS 2012: Scientific Platform Presentations (Session I)
63 Functional Connectivity in Patients with Clinically Isolated Optic NeuritisGregory P. Van Stavern; Beau Ances; Gregory Wu; Mae Gordon; Julie HueckerNANOS 2013: Platform Presentations (Session II)
64 Functional Connectivity in Patients with Clinically Isolated Optic NeuritisGregory P. Van Stavern; Beau Ances; Gregory Wu; Mae Gordon; Julie HueckerNANOS 2013: Platform Presentations (Session II)
65 Further Characterization of the Melanopsin-Mediated Pupillary Light Reflex in Multiple SclerosisMarlen Lucero; Ethan Meltzer; Peter Sguigna; Mirna Lucero; Amy Conger; Darrel Conger; Victoria Stokes; Josh Beh; Rob Rennaker; Laura Balcer; Peter Calabresi; Teresa Frohman; Randy Kardon; Elliot FrohmanNANOS 2014: Poster Presentations
66 Gender and retinal nerve fiber layer thickness in patients with non-acute optic neuritisJessie Trufyn; Fiona CostelloNANOS 2012: Poster Presentations
67 Gene Expression Patterns of Peripheral Blood-Cells Subpopulations in Acute Optic NeuritisRuth Huna-Baron; Anna Feldman; Michael Gurevich; Anat AchironNANOS 2009: Scientific Platform Presentations (Session I)
68 Historical Perspective on the Diagnosis and Treatment of Optic NeuritisNicholas J. VolpeNANOS 2001: Optic Neuritis and Multiple Sclerosis Symposium
69 Homonymous Hemianopia as a Clinically Isolated Syndrome Heralding Multiple SclerosisArchana Abhayambika; Arun N. E. Sundaram; James A. SharpeNANOS 2010: Poster Presentations
70 How Do Retinal Nerve Fiber Layer Axonal Loss and Visual Dysfunction Affect Quality of Life in MS?A. Daniels; J. Fisher; D. Jacobs; C. Markowitz; S. Galetta; N. Volpe; M. L. Nano-Schiavi; M. Baier; G. Cutter; H. Winslow; P. Calabresi; M. Maguire; L. BalcerNANOS 2006: Poster Presentations
71 Humoral Immunity in Optic Neuritis and Multiple SclerosisJeffrey L. Bennett, MDNANOS 2007: Immunological Diseases in Neuro-Ophthalmology
72 Idiopathic Chiasmal NeuritisAki Kawasaki; Valerie PurvinNANOS 2007: Poster Presentations
73 Immunoglobin Heavy-Chain Repertoire Bias and the Risk of Demyelinating Disease in Isolated Optic NeuritisJ. Bennett; A. Ritchie; K. Haubold; D. Gilden; G. OwensNANOS 2006: Scientific Platform Presentations (Session I)
74 Immunoglobulin TherapyShelley A. Cross, MDNANOS 1995: Visual System Injury Symposium
75 Immunology of Multiple SclerosisBarry G. W. AmasonNANOS 1996: Multiple Sclerosis Symposium
51 - 75 of 238